Ankylosing hyperostosis [Forestier]

M13_FORESTIER

diffuse idiopathic skeletal hyperostosis: This syndrome is characterized by the association of ankylosing vertebral hyperostosis with hyperkeratosis of the soles and palms.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 M48.1

Hospital discharge: ICD-9 7216

Hospital discharge: ICD-8 $!$

Cause of death: ICD-10 M48.1

Cause of death: ICD-9 7216

Cause of death: ICD-8 $!$

292

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

292

Check minimum number of events None

292

Include endpoints None

292

M13_FORESTIER

Extra metadata

Level in the ICD hierarchy 4

First used in FinnGen datafreeze DF2

Parent code in ICD-10 M48

Name in latin Hyperostosis ancylopoetica

Similar endpoints

↥

List of similar endpoints to Ankylosing hyperostosis [Forestier] based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	283	123	160
Unadjusted prevalence (%)	0.09	0.07	0.12
Mean age at first event (years)	58.29	57.25	59.09

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: M13_FORESTIER – Ankylosing hyperostosis [Forestier]
GWS hits: 0

Survival analyses between endpoints

↥

Plot

before Ankylosing hyperostosis [Forestier]
after Ankylosing hyperostosis [Forestier]

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Ankylosing hyperostosis [Forestier]

↥